| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 124 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 119 |
| 2 | TACROLIMUS OINTMENT 0.1% | 119 |
| 3 | PREDNISONE | 115 |
| 4 | MYCOPHENOLATE MOFETIL | 64 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 64 |
| 6 | METHYLPREDNISOLONE | 61 |
| 7 | PREDNISOLONE | 44 |
| 8 | PREDNISOLONE ORAL | 44 |
| 9 | PREDNISOLONE ORAL SOLUTION | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VALGANCICLOVIR | 42 | 0.0022 |
| 1 | MYCOPHENILIC ACID | 37 | 0.0017 |
| 2 | MYCOPHENOLIC ACID | 37 | 0.0011 |
| 3 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 4 | IMIPENEM AND CILASTATIN SODIUM | 2 | 0.0009 |
| 5 | TACROLIMUS OINTMENT 0.1% | 119 | 0.0009 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 119 | 0.0009 |
| 7 | TACROLIMUS | 124 | 0.0008 |
| 8 | REMDESIVIR | 9 | 0.0007 |
| 9 | PLERIXAFOR | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 41 | 0.0018 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 37 | 0.0017 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 9 | 0.0007 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 4 | Penem Antibacterial [EPC] | 19 | 0.0006 |
| 5 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 6 | Oxazolidinone Antibacterial [EPC] | 14 | 0.0005 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 8 | Polyene Antifungal [EPC] | 14 | 0.0003 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |